Featured Insights and Perspectives from Darwin
The latest insights, ideas, and perspectives from Darwin, updated weekly. Explore a cross-section of up-to-date content from us and other thought leaders on trends in health care, research, and data.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
News and Insights
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Results 1
Date
July 25, 2022
Our Take: Amazon plans to acquire primary care provider One Medical for $3.9 billion
Learn More
July 25, 2022
Value-based care and alternative payment models
August 1, 2022
Our Take: Humana to streamline its operations into two units: Insurance Services and CenterWell
Learn More
August 1, 2022
Health policy, CMS initiatives and health economics
August 8, 2022
Our Take: CVS could make major primary care acquisition by year-end, execs suggest on earnings call
Learn More
August 8, 2022
Value-based care and alternative payment models
August 15, 2022
Our Take: HCA Healthcare partners with J&J to improve health equity, patient outcomes, support for nurses
Learn More
August 15, 2022
Health policy, CMS initiatives and health economics
August 22, 2022
Our Take: Health systems continue to report dismal financial results in Q2, blunted by labor expenses and poor investment performance
Learn More
August 22, 2022
IDN trends, challenges, and leadership
August 29, 2022
Digital health and emerging technologies
.jpg)
September 12, 2022
Our Take: CVS Health wins bidding contest with offer to acquire Signify Health for approximately $8 billion
Learn More
September 12, 2022
IDN trends, challenges, and leadership
.jpg)
September 26, 2022
Our Take: Humana to acquire primary care centers opened in private equity JV for up to $550 million
Learn More
September 26, 2022
Value-based care and alternative payment models
October 3, 2022
Our Take: Eisai, Biogen’s lecanemab slowed clinical decline by 27% in Phase III Alzheimer’s trial
Learn More
October 3, 2022
Health policy, CMS initiatives and health economics
October 10, 2022
Our Take: Amylyx’s investigational ALS drug gains FDA approval, but the controversy continues
Learn More
October 10, 2022
Pharma strategy, engagement, and market access
.jpg)
October 17, 2022
IDN trends, challenges, and leadership
October 24, 2022
Our Take: Analysts predict Apple will enter the health insurance market in 2024, Forbes reports
Learn More
October 24, 2022
Health policy, CMS initiatives and health economics
Stay Aware. Stay Informed.
Want to stay ahead of health care trends?
Sign up for highly curated, expert weekly strategic insights for health care executives and leaders.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
